RMTI NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Rockwell Medical Inc · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 7.19 USD
8.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -14.1% below the Trend Line and sits at 14.3% of its 52-week range. The latest completed week returned 8.4%, after a 29.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 24/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 12d.

Setup score 24 out of 100
Latest Close 7.19 USD 31 Jul 2026
1W Return 8.4% latest completed week
4W Return 29.8% short-term follow-through
12W Return -13.8% quarterly tape
Trend Breadth 11.5% 6 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 8.4% Latest completed week; four-week move 29.8%. Indicator stack 6/33 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.17% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 24/100 conviction; expected move 19.6%. News sentiment 56/100 51 relevant articles in the latest sentiment read. Event risk 12d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -14.1% below the Trend Line and sits at 14.3% of its 52-week range. The latest completed week returned 8.4%, after a 29.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0212-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 29.8% over four weeks, -13.8% over 12 weeks, and -24.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W8.4%
4W29.8%
12W-13.8%
26W-32.8%
52W-24.8%
Active trend streak0 weeks
Active weeks in one year6
Trend breadth11.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.04Latest activity-pressure read.
Pressure change18.8%Four-week change in activity pressure.
Leadership-32.46Latest relative-leadership reading.
RS change37.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength40/100Blend of value, momentum, and quality. Underlying universe rank 61; rank 1 is best.
Value45/100Relative valuation strength. Underlying universe rank 56; rank 1 is best.
Quality44/100Profitability and accounting quality. Underlying universe rank 57; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth45/100Revenue and earnings growth. Underlying universe rank 56; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
17.1%
Gross profit retained from each unit of revenue.
Operating margin
-6.3%
Operating profit retained from revenue.
Free-cash-flow margin
5.3%
Free cash flow generated from revenue.
Return on invested capital
-7.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-30.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-11.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-29.9%
Net share repurchases relative to market value.
Shareholder yield
-29.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

RMTI shows mixed options pressure with a 24/100 conviction score, put-call volume ratio of 1.00, expected move of 19.6%, and Sharemaestro trend signal inactive.

Conviction24/100
Expected move19.6%
Put/call volume1.00
Pressure12
Speculation4
Volatility58
Trend agreement48
Open options detail
Insider activity10 / 0

10 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 51 relevant articles.

15 positive · 31 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings12dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move19.6%Nearest-chain priced movement where available.
52-week drawdown-65.8%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+17.2%Week of 20 Mar.
Worst week-17.1%Week of 27 Mar.
Latest week+8.4%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses2
Sharp losses12
Recent vol7.2%13-week weekly-return volatility.
Base vol10.5%52-week weekly-return volatility.
Up/down split22/29Count of positive and negative weeks in the 52-week window.
Average skew8.3% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape14/100

Trend, activity pressure, participation, and risk combine to a 14/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.02; No reversal markers Next-Week ExpectancyNegative 41.17%

Next-week expectancy is negative with a 41.17% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors42/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 54; Buyback Yield rank 93 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options42/100

RMTI shows mixed options pressure with a 24/100 conviction score, put-call volume ratio of 1.00, expected move of 19.6%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 19.6% Sentiment56/100

Weighted news tone is neutral across 51 relevant articles.

Rockwell Medical, Inc. Revenue Breakdown – LSX:A42EKB Insiders10 / 0

10 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings12d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20267.19 USD8.4%8.37 USD15.93 USD-1.04-32.46141.9KOff
24 Jul 20266.63 USD8.2%8.42 USD16.09 USD-1.35-37.91152.8KOff
17 Jul 20266.12 USD9.2%8.49 USD16.27 USD-1.48-44.19162.3KOff
10 Jul 20265.61 USD1.3%8.57 USD16.49 USD-1.43-51.65218.9KOff
3 Jul 20265.54 USD-14.9%8.69 USD16.66 USD-1.28-52.122.3MOff
26 Jun 20266.51 USD1.7%8.83 USD16.95 USD-1.18-43.721.3MOff
19 Jun 20266.40 USD2.4%8.95 USD17.26 USD-1.08-47.49943.8KOff
12 Jun 20266.25 USD-6.0%9.03 USD17.51 USD-0.98-47.871.6MOff
5 Jun 20266.64 USD-10.6%9.13 USD17.74 USD-0.93-43.882.5MOff
29 May 20267.43 USD-6.3%9.23 USD17.99 USD-0.82-40.711.2MOff
22 May 20267.93 USD0.1%9.36 USD18.21 USD-0.74-35.581.1MOff
15 May 20267.92 USD-5.0%9.48 USD18.31 USD-0.60-35.471.0MOff
8 May 20268.34 USD-6.1%9.61 USD18.41 USD-0.37-32.912.1MOff
1 May 20268.88 USD1.8%9.69 USD18.52 USD-0.24-25.53894.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.